TOP STORY Ronin Recruits Protein Allies to Sustain Embryonic Stem Cell Growth Ronin, crucial to the self-renewal of embryonic stem cells, and a co-regulator called Hcf-1 bind to a small strand of DNA called a hyperconserved enhancer element to control a gene “program” that stimulates growth of stem cells and may even play a role in cancer. [Press release from the Baylor College of Medicine discussing online prepublication in Genes and Development]
|
SCIENCE NEWS Chromosomal Variations Found in Early Passage Female Embryonic Stem Cells Scientists have uncovered that variations in X chromosome inactivation take place in very early passages of female human embryonic stem cells lines. [Press release from EurekAlert! discussing online prepublication in PLoS One] University of Texas Medical Branch Grows Lung from ‘Skeletons’ Specialists in the field of tissue engineering have been frustrated by the problem of coaxing undifferentiated stem cells to develop into the specific cell types that populate different locations in the lung. Now, researchers have demonstrated a potentially revolutionary solution to this problem. [Press release from the University of Texas Medical Branch discussing online prepublication in Tissue Engineering Part A] Building a Substitute Pancreas for Diabetics Implants containing specially wrapped insulin-producing cells derived from embryonic stem cells can regulate blood sugar in mice for several months. [Press release from MIT Technology Review discussing research presented at the 8th Annual Meeting of the International Society for Stem Cell Research]
|
POLICY NEWS U.S. Appeals Court Reinstates Stem Cell Suit A U.S. appeals court reinstated a lawsuit that challenges an Obama administration policy for federal funding of some human embryonic stem cell research. [Court of Appeals, United States] NIH Director Formalizes Rejection of Diseased Stem Cell Lines The director of the National Institutes of Health (NIH) approved eight more human embryonic stem cell lines for federal funding. His decision brings to 75 those lines now available to NIH-supported researchers under President Barack Obama’s liberalized, 2009 policy. [National Institutes of Health, United States] Research Budgets Face Austerity in 2012 The National Institutes of Health and other life sciences and biomedical research funding agencies will need to trim their budgets for 2012, which are to be planned over the summer, to satisfy a White House that is now stressing deficit reduction and belt-tightening after two years of stimulus funding-boosted research budgets. [The Office of Management and Budget, United States] The Reality of Human Stem Cell Research in Europe A new report from the European Science Foundation examines the key scientific questions for human stem cell research in the context of the rapidly emerging field of regenerative medicine. [European Science Foundation, European Union] Public Wants Synthetic Biology Regulated, Survey Says According to the most extensive public survey yet, the British public are at ease with the idea of synthetic biology — but only if it is responsibly regulated. [Biotechnology and Biological Sciences Research Council, United Kingdom] Strong Medicine for French Research The medical-research adviser to France’s president aims to shift power and money to universities. [National Research Agency, France] The 7th Annual TOPRA (The Organization for Professionals in Regulatory Affairs) Symposium This annual symposium is for all those involved within regulatory affairs and brings together representatives of industry and the regulatory agencies and the European Commission to discuss and understand today’s regulatory issues and debate the future plans for regulation. [Medicines and Healthcare Products Regulatory Agency, United Kingdom] Center for Scientific Review; Notice of Closed Meetings [National Institutes of Health, Untied States] Biophysical and Biomechanical Aspects of Embryonic Development (R01) (PAR-10-221) [National Heart, Lung, and Blood Institute, United States] Biophysical and Biomechanical Aspects of Embryonic Development (R21) (PAR-10-222) [National Heart, Lung, and Blood Institute, United States] Science Board Advisory Committee; Notice of Meeting [Docket No. FDA-2010-N-0001] [Food and Drug Administration, United States] Implementation of the Biologics Price Competition and Innovation Act of 2009 [Food and Drug Administration, United States] Public Meeting Notice: Maryland Stem Cell Research Commission [Maryland Stem Cell Research Commission, United States] |
EVENTS Worldwide Innovative Networking (WIN) Symposium in Personalized Cancer Medicine July 7-9, 2010 Paris, France United Kingdom National Stem Cell Network (UKNSCN) 3rd Annual Scientific Conference July 12-14, 2010 Nottingham, United Kingdom
2nd International Conference on Cellular and Molecular Bioengineering (ICCMB2) August 2-4, 2010 Singapore
Select Biosciences 3rd Annual Stem Cells Europe Conference August 24-25, 2010 Edinburgh, Scotland Select Biosciences Inaugural Cellular Therapy Summit August 24-25, 2010 Edinburgh, Scotland
International Society for Cellular Therapy (ISCT) – Europe 2nd Regional Meeting September 11-14, 2010 Belgirate, Italy
Stem Cells USA & Regenerative Medicine Congress 2010 September 13-15, 2010 Philadelphia, United States Tissue Engineering & Regenerative Medicine International Society (TERMIS) – Asia Pacific 2010 September 15-17, 2010 Sydney, Australia 5th World Congress on Preventive & Regenerative Medicine (WCRM) 2010 October 5-7, 2010 Hannover, Germany
Fraunhofer Life Science Symposium Leipzig 2010 October 29-30, 2010 Leipzig, Germany
Select Biosciences 2nd International Forum on Stem Cells November 12-13, 2010 Tianjin, China Stem Cell Network 10th Annual Scientific Meeting November 22-24, 2010 Calgary, Canada Tissue Engineering & Regenerative Medicine International Society (TERMIS) – North America 2010 Annual Conference December 5-8, 2010 Orlando, United States
Stem Cells World Congress January 24-25, 2011 San Diego, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Senior Scientist – Magnetic Cell Separation (STEMCELL Technologies) Business Development Manager Europe – Cell Therapy Products (Pall Corporation)
Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with ESC & iPSC News. Visit here to post your career opportunities.
|
|